Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2010 | 2 |
2011 | 3 |
2018 | 1 |
2019 | 1 |
2021 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia.
N Engl J Med. 2019 Jan 3;380(1):11-22. doi: 10.1056/NEJMoa1812792. Epub 2018 Nov 10.
N Engl J Med. 2019.
PMID: 30415628
Clinical Trial.
Icosapent Ethyl Reduces Ischemic Events in Patients With a History of Previous Coronary Artery Bypass Grafting: REDUCE-IT CABG.
Verma S, Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Dhingra NK, Ketchum SB, Juliano RA, Jiao L, Doyle RT Jr, Granowitz C, Gibson CM, Pinto D, Giugliano RP, Budoff MJ, Mason RP, Tardif JC, Ballantyne CM; REDUCE-IT Investigators.
Verma S, et al.
Circulation. 2021 Dec 7;144(23):1845-1855. doi: 10.1161/CIRCULATIONAHA.121.056290. Epub 2021 Oct 28.
Circulation. 2021.
PMID: 34710343
Free article.
Clinical Trial.
Item in Clipboard
Implementing cardiovascular risk reduction in patients with cardiovascular disease and diabetes mellitus.
Nandish S, Wyatt J, Bailon O, Smith M, Oliveros R, Chilton R.
Nandish S, et al. Among authors: wyatt j.
Am J Cardiol. 2011 Aug 2;108(3 Suppl):42B-51B. doi: 10.1016/j.amjcard.2011.03.015.
Am J Cardiol. 2011.
PMID: 21802580
Review.
Item in Clipboard
A cardiologist's view of hypoglycemia.
Nandish S, Wyatt J, Oliveros R, Zion AS, Lujan M, Chilton R.
Nandish S, et al. Among authors: wyatt j.
Curr Atheroscler Rep. 2010 Mar;12(2):88-95. doi: 10.1007/s11883-010-0093-8.
Curr Atheroscler Rep. 2010.
PMID: 20425243
Review.
Item in Clipboard
Cardiovascular comorbidities of type 2 diabetes mellitus: defining the potential of glucagonlike peptide-1-based therapies.
Chilton R, Wyatt J, Nandish S, Oliveros R, Lujan M.
Chilton R, et al. Among authors: wyatt j.
Am J Med. 2011 Jan;124(1 Suppl):S35-53. doi: 10.1016/j.amjmed.2010.11.004.
Am J Med. 2011.
PMID: 21194579
Review.
Item in Clipboard
Vasculotoxic effects of insulin and its role in atherosclerosis: what is the evidence?
Nandish S, Bailon O, Wyatt J, Smith J, Stevens A, Lujan M, Chilton R.
Nandish S, et al. Among authors: wyatt j.
Curr Atheroscler Rep. 2011 Apr;13(2):123-8. doi: 10.1007/s11883-011-0165-4.
Curr Atheroscler Rep. 2011.
PMID: 21287301
Review.
Item in Clipboard
Effect of glitazones on the progression of coronary artery disease in type 2 diabetes patients.
Wyatt J, Nandish S, Oliveros R, Zion AS, Lujan MS, Chilton R.
Wyatt J, et al.
Vasc Health Risk Manag. 2010 Feb 4;6:1-8.
Vasc Health Risk Manag. 2010.
PMID: 20191077
Free PMC article.
Review.
Item in Clipboard
Cite
Cite